Apriem Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Apriem Advisors’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,028	Closed	-$22K	–	328
2018 Q2	$22K	Buy	+1,028	New	+$20.1K	﹤0.01%	341

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Apriem Advisors's SBRA Position: Q3 2018 in Review

Apriem Advisors sold out of Sabra Healthcare REIT (SBRA) in Q3 2018, closing a stake of 1,028 shares — an estimated $22K sold.

Apriem Advisors first reported a position in SBRA in Q2 2018 and held it in 1 quarter. The position peaked at $22K in Q2 2018. 335 funds tracked by Wall St. Rank hold SBRA as of Q3 2018.

Apriem Advisors reported no remaining Sabra Healthcare REIT position as of Q3 2018 after selling out during the quarter.
Apriem Advisors sold 1,028 Sabra Healthcare REIT shares in Q3 2018, an estimated $22K.
Apriem Advisors first reported a position in Sabra Healthcare REIT in Q2 2018 and held it in 1 quarter.
Apriem Advisors's Sabra Healthcare REIT position peaked at $22K in Q2 2018.
335 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2018.

Based on Apriem Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.